← FDA Drug Approvals (Drugs@FDA)

ARIPIPRAZOLE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: HETERO LABS LTD III · Approved 2023-11-01

Drug application

FDA Application #

ANDA216150

Application type

Abbreviated New Drug Application (Generic)

Brand name

ARIPIPRAZOLE

Generic name

ARIPIPRAZOLE ORAL

Active ingredients

ARIPIPRAZOLE

Dosage form

SOLUTION

Route

ORAL

Marketing status

Prescription

Sponsor

HETERO LABS LTD III

Manufacturer

Camber Pharmaceuticals, Inc.

First approval

2023-11-01

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown